Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    pr610
Previous Study | Return to List | Next Study

A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors

This study has been terminated.
(Study was prematurely discontinued due to unacceptable toxicity.)
Information provided by (Responsible Party):
Proacta, Incorporated Identifier:
First received: June 7, 2012
Last updated: June 13, 2014
Last verified: June 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)